Advertisement

Desmopressin Injection

[15 July 2016]

Products Affected - Description

DDAVP injection, Ferring
4 mcg/mL, 1 mL ampule, 10 count (NDC 00075-2451-01) - discontinued
4 mcg/mL, 10 mL multiple dose vial, 1 count (NDC 00075-2451-5)  - discontinued
 
Desmopressin Acetate injection, Caraco
4 mcg/mL, 10 mL multiple dose vial, 1 count (NDC 62756-0529-40)
 
Desmopressin Acetate injection, Ferring
4 mcg/mL, 1 mL ampule, 10 count (NDC 55566-5030-01)
4 mcg/mL, 10 mL multiple dose vial, 1 count (NDC 55566-5040-01)
 
Desmopressin Acetate injection, Hospira
4 mcg/mL, 1 mL ampule, 10 count (NDC 00409-2265-01)
 
Desmopressin Acetate injection, Teva
4 mcg/mL, 1 mL vial, 10 count (NDC 00703-5051-03)
4 mcg/mL, 10 mL multiple dose vial, 1 count (NDC 00703-5054-01)

Reason for the Shortage

  • Teva and Hospira have desmopressin injection on shortage due to manufacturing delays.
  • Ferring divested generic desmopressin to Amring Pharmaceuticals in January 2016.

Available Products

DDAVP injection, Ferring
4 mcg/mL, 1 mL ampule, 10 count (NDC 55566-2200-00)
4 mcg/mL, 10 mL multiple dose vial, 1 count (NDC 55566-2300-00)
 
Desmopressin Acetate injection, Amring Pharmaceuticals
4 mcg/mL, 1 mL ampule, 10 count (NDC 69918-0899-10)
4 mcg/mL, 10 mL vial, 1 count (NDC 69918-0901-10)

Estimated Resupply Dates

  • Caraco cannot provide availability information at this time.
  • Hospira has desmopressin 4 mcg/mL 1 mL ampules on back order and the company cannot estimate a release date.
  • Teva has desmopressin 4 mcg/mL 1 mL and 10 mL vials on long-term back order and the company estimates a release date in fourth quarter of 2017.

Related Shortages

Updated

July 15, April 28, February 4, 2016; December 21, November 12, September 9, July 13, June 22, May 4, April 6, March 23, February 25 and 2, January 23, 2015; November 19, August 29, July 23, June 26 and 3, May 7, March 25, 2014; December 20, September 30, July 25, May 6, March 28, February 8, January 18, 2013; December 31, 21 and 7, November 13, October 22 and 3, September 5, August 8, June 19, May 16 and 9, April 26, March 29, January 18, 2012; December 29, November 3, October 4, August 18, July 8, May 27, April 21 and 7, March 23, February 16 and 3, January 6, 2011; December 15 and 2, November 19, October 29 and 14, September 23, August 24, 16, 11 and 3, July 30 and 7, 2010, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing